sever
acut
respiratori
syndromecoronaviru
sarscov
sarslik
coronaviru
potenti
threat
global
health
howev
review
longterm
effect
clinic
treatment
sar
patient
lack
total
recov
sar
patient
recruit
year
infect
clinic
questionnair
respons
examin
find
indic
patient
experienc
variou
diseas
includ
lung
suscept
infect
tumor
cardiovascular
disord
abnorm
glucos
metabol
compar
healthi
control
metabolom
analys
identifi
signific
differ
serum
metabolom
sar
survivor
signific
metabol
disrupt
comprehens
increas
phosphatidylinositol
lysophospha
tidylinositol
level
recov
sar
patient
coincid
effect
methylprednisolon
administr
investig
steroid
treat
nonsar
patient
sever
pneumonia
result
suggest
highdos
puls
methylprednisolon
might
caus
longterm
system
damag
associ
serum
metabol
alter
present
studi
provid
inform
improv
understand
coronavirusassoci
patholog
might
permit
optim
clinic
treatment
sever
acut
respiratori
syndrom
sar
caus
coronaviru
sarscov
affect
countri
five
contin
soon
identifi
sevenmonthold
infant
bronchiol
conjunct
follow
later
middl
east
respiratori
syndrom
coronaviru
merscov
rapidli
spread
worldwid
fatal
rate
sever
report
recent
demonstr
exist
sarslik
coronaviru
indic
coronavirusassoci
respiratori
tract
infect
continu
signific
epidem
potenti
therefor
remain
urgent
requir
standard
treatment
order
develop
effect
intervent
strategi
coronavirusassoci
diseas
clinic
treatment
implement
follow
sudden
outbreak
sarscov
includ
empir
experiment
type
although
effect
side
effect
remain
controversi
antivir
drug
includ
ribavirin
lopinavir
ritonavir
prescrib
soon
sarscov
identifi
caus
agent
type
interferon
also
use
owe
inhibitori
effect
sarscov
replic
furthermor
use
convalesc
plasma
immunoglobulin
report
treatment
sar
frequent
corticosteroid
includ
methylprednisolon
alon
combin
antivir
drug
administ
sar
patient
prevent
immunopatholog
lung
damag
although
time
dosag
regimen
steroid
administr
controversi
administr
highdos
puls
methylprednisolon
associ
psychic
derang
acut
myopathi
osteonecrosi
consid
fact
disord
usual
progress
chronic
state
propos
sar
survivor
may
suffer
metabol
disturb
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
scientif
report
result
system
patholog
longterm
metabolit
includ
phosphatidylinositol
pi
lysophosphatidylinositol
lpi
associ
cellular
entri
andor
egress
respiratori
virus
howev
remain
unknown
whether
serum
level
pi
lpi
disregul
recoveri
sar
infect
present
studi
metabolom
base
ultrahighperform
liquid
chromatographymass
spectrometri
uplcm
ga
chromatographymass
spectrometri
gcm
adopt
assess
comprehens
metabolit
profil
serum
urin
sampl
sar
patient
year
follow
clinic
recoveri
observ
recov
sar
patient
affect
variou
serum
metabol
disord
predominantli
associ
lipid
metabol
includ
hyperlipidemia
hl
cardiovascular
abnorm
cva
abnorm
glucos
metabol
agm
demograph
recov
sar
patient
year
follow
recoveri
recruit
sarscov
survivor
ultim
complet
studi
procedur
discontinu
particip
studi
three
dropout
one
protocol
deviat
two
miss
compar
healthi
control
patient
complet
studi
includ
men
women
averag
age
year
averag
bodi
weight
kg
averag
bodi
mass
index
kgm
significantli
differ
healthi
volunt
tabl
none
recov
sar
patient
smoke
drink
habit
sarscov
infect
patient
treat
methylprednisolon
averag
mg
mean
period
day
maximum
daili
dose
mg
tabl
respons
questionnair
indic
sinc
recoveri
recov
sar
patient
readmit
hospit
least
four
experienc
osteonecrosi
femor
head
one
due
fetal
death
two
diagnos
hysteromyoma
one
osphyarthrosi
one
cervic
spondylosi
one
spinal
cord
tumor
one
breast
cancer
data
shown
sixteen
recov
sar
patient
suffer
lung
infect
past
year
tabl
suscept
respiratori
tract
also
suggest
fact
subject
report
cold
least
five
time
past
year
compar
healthi
volunt
patient
report
less
five
cold
past
year
data
shown
addit
recov
sar
patient
tendenc
hl
cva
agm
tabl
urin
screen
detect
red
blood
cell
sar
subject
patient
exhibit
abnorm
urin
protein
level
subject
recov
sar
group
neutrophil
ratio
triiodothyronin
level
normal
rang
respect
healthi
volunt
respect
similarli
compar
healthi
volunt
subject
recov
sar
group
triglycerid
tg
level
lowdens
lipoprotein
concentr
vldlc
normal
rang
tabl
togeth
health
survey
fig
data
demonstr
recov
sar
patient
poor
qualiti
life
year
follow
recoveri
suscept
inflamm
tumor
glucos
lipid
metabol
disord
alter
serum
metabolom
although
signific
differ
observ
abund
metabolit
urin
sampl
sar
healthi
volunt
partial
least
squaresdiscrimin
analysi
plsda
show
signific
differ
serum
metabolom
recov
sar
patient
healthi
control
fig
data
point
cluster
two
distinct
group
plot
map
obvious
separ
recov
sar
patient
healthi
control
fig
major
differenti
express
metabolit
includ
acid
cystein
longchain
acylcarnitin
carnitin
fructos
pyroglutam
acid
myoinositol
phosphat
upregul
serum
sampl
recov
sar
patient
compar
healthi
volunt
fig
metabolit
decreas
recov
sar
patient
compar
healthi
volunt
includ
methyl
ester
acid
hexadecano
acid
free
carnitin
arginin
fig
investig
potenti
metabol
disrupt
recov
sar
patient
alter
metabolit
abund
associ
metabol
pathway
level
lactic
acid
deriv
glycolysi
elev
recov
sar
patient
compar
healthi
volunt
fig
similarli
level
cystein
aspart
acid
alanin
convert
pyruv
acid
well
level
succin
acid
intermedi
tricarboxyl
acid
cycl
tca
cycl
elev
recov
sar
patient
compar
healthi
volunt
addit
serum
level
prolin
histin
pyroglutam
acid
convert
glutam
acid
enter
tca
cycl
energi
product
substanc
synthesi
increas
sar
patient
compar
healthi
volunt
level
free
carnitin
decreas
sar
patient
compar
healthi
volunt
level
carnitin
increas
fig
ratio
carnitin
free
carnitin
also
increas
fig
suggest
fatti
acid
could
easili
enter
mitochondria
recov
sar
patient
serum
level
sarcosin
spermidin
increas
recov
sar
patient
compar
healthi
volunt
wherea
level
citrullin
arginin
intermedi
urea
cycl
decreas
fig
thu
suggest
increas
requir
arginin
urea
cycl
recov
sar
patient
sever
pathway
exist
synthesi
phospholipid
neutral
lipid
includ
fatti
acid
rearrang
via
remodel
process
fig
serum
level
pi
significantli
increas
recov
sar
patient
compar
healthi
volunt
fig
addit
pi
level
posit
correl
level
lowdens
lipoprotein
vldl
recov
sar
patient
fig
c
furthermor
vldl
posit
correl
total
tg
control
recov
sar
group
fig
c
result
suggest
de
novo
synthesi
pi
promot
sarscov
infect
cluster
analysi
perform
assess
associ
among
differenti
express
lipid
recov
sar
patient
three
lpi
lpi
associ
respect
precursor
pi
cij
respect
nevertheless
ffa
correl
lpi
lpi
cij
respect
illustr
enhanc
level
pi
remodel
recov
sar
patient
lpi
produc
associ
releas
ffa
recov
sar
patient
compar
healthi
volunt
may
due
elev
level
pi
thu
sar
patient
may
sensit
activ
fig
lpi
ratio
elev
ffa
ratio
significantli
decreas
recov
sar
patient
indic
lpi
remain
follow
cleavag
wherea
releas
ffa
pi
rapidli
use
eicosanoid
synthesi
fig
effect
steroid
treatment
lipid
metabol
highdos
steroid
treatment
could
contribut
alter
lipid
metabol
serum
recov
sar
patient
next
investig
shortterm
effect
methylprednisolon
treatment
nonsar
patient
sever
pneumonia
twenti
three
nonsar
patient
sever
pneumonia
treat
steroid
includ
men
women
year
old
mg
methylprednisolon
mean
period
day
twenti
three
nonsar
patient
sever
pneumonia
without
steroid
treatment
includ
men
women
year
old
coincid
former
find
level
detect
pi
significantli
higher
steroidtr
group
without
steroid
treatment
tabl
although
dose
steroid
use
nonsar
patient
much
less
sra
patient
result
extent
suggest
steroid
treatment
could
increas
level
serum
pi
although
sarscov
survivor
benefit
clinic
treatment
target
viru
inflamm
recov
patient
current
studi
continu
experi
poor
qualiti
life
year
infect
previou
studi
report
pulmonari
ventil
function
recov
sar
survivor
normal
signific
proport
recov
patient
report
lung
infect
hl
cva
agm
sequela
serum
metabolom
analys
identifi
system
metabol
alter
patient
predomin
metabol
dysregul
observ
serum
serum
level
pi
lpi
ffa
lpc
show
greatest
disrupt
compar
differenti
express
metabolit
lpi
pi
markedli
upregul
recov
sar
patient
serum
level
lpi
pi
influenc
sequela
observ
survivor
tabl
subject
regroup
base
metabol
syndrom
statist
analys
subgroup
indic
identifi
metabol
alter
associ
hl
cva
agm
fig
result
suggest
earli
steroid
treatment
could
effect
serum
level
pi
lpi
recov
sar
patient
howev
rat
experi
level
detect
pi
rat
intraperiton
inject
methylprednisolon
group
mgkg
compar
untreat
rat
tabl
suggest
effect
steroid
treatment
serum
lipid
metabol
complex
thought
pi
previous
relat
viral
infect
associ
lung
exampl
membran
bind
penetr
ebola
viru
fusion
peptid
requir
presenc
pl
target
membran
downstream
element
pi
signal
pathway
shown
involv
viral
entri
ebola
viru
matrix
protein
recent
shown
requir
pl
extens
oligomer
viral
egress
pl
hypothes
role
cellular
entri
pseudovirus
bear
sarscov
spike
protein
cell
entri
mediat
sarscov
spike
protein
strongli
inhibit
knockdown
therefor
upregul
pi
sar
patient
may
promot
sarscov
infect
entri
howev
pl
also
shown
suppress
respiratori
syncyti
viru
infect
mice
lpi
thought
critic
role
glucos
homeostasi
larg
proport
recov
sar
patient
report
glucos
metabol
disord
includ
hyperinsulinemia
insulin
resist
hyperglycemia
type
diabet
year
prior
studi
lpi
stimul
insulin
releas
activ
gprotein
coupl
receptor
increas
plasma
insulin
level
glucos
toler
lipidom
analys
also
demonstr
increas
lpi
level
pretyp
diabet
mous
model
present
studi
increas
rate
glycolysi
effect
tca
cycl
observ
recov
sar
patient
suggest
associ
lpi
glucos
metabol
recov
sar
patient
result
broad
express
across
variou
tissu
lpi
exert
divers
regulatori
role
includ
excit
dorsal
root
ganglion
neuron
intestin
inflamm
migrat
orient
human
breast
cancer
may
explain
variou
symptom
observ
recov
sar
patient
lpiassoci
disord
may
persist
long
high
serum
lpi
level
remain
number
limit
associ
present
studi
first
rule
possibl
patient
glucos
metabol
disord
taken
medic
prior
analys
may
influenc
physiolog
statu
second
although
endeavor
recruit
mani
recov
patient
possibl
sampl
size
small
third
best
control
investig
steroid
treatment
effect
recruit
sar
patient
without
steroid
treatment
lack
control
nonsar
patient
sever
pneumonia
without
steroid
treatment
collect
present
studi
may
exactli
mimic
two
key
element
sar
infect
steroid
treatment
sar
viru
infect
therefor
reason
mark
increas
serum
level
lpi
pi
recov
sar
patient
requir
investig
chang
metabolit
level
observ
studi
may
reflect
real
situat
exactli
primari
organ
damag
sar
infect
lung
function
improv
gradual
year
profound
metabol
disrupt
may
also
directli
indirectli
relat
initi
damag
lung
result
sarscov
infect
lung
damag
may
result
complex
organ
respons
infect
highdos
puls
steroid
treatment
importantli
find
may
improv
understand
coronavirusinduc
patholog
mechan
may
aid
develop
improv
measur
treatment
control
coronaviru
infect
continu
threaten
human
health
worldwid
ethic
statement
written
inform
consent
obtain
studi
particip
institut
review
board
tianjin
haih
hospit
provid
written
approv
judg
method
studi
met
relev
ethic
guidelin
regul
ethic
subject
thirtyon
sar
survivor
outbreak
well
agematch
consent
healthi
volunt
medic
staff
tianjin
haih
hospit
recruit
gener
particip
inform
includ
age
diseas
durat
medic
collect
use
standard
form
student
ttest
twotail
use
evalu
differ
two
group
furthermor
particip
complet
symptom
questionnair
regard
medic
histori
sinc
sar
infect
fast
overnight
serum
urin
sampl
collect
morn
patient
routin
clinic
measur
metabolom
analysi
lipid
metabol
investig
serum
sampl
also
collect
nonsar
patient
sever
pneumonia
half
patient
treat
methylprednisolon
clinic
measur
evalu
gener
physic
abil
patient
includ
qualiti
life
score
medic
outcom
studi
short
harri
hip
score
sixmin
walk
test
assess
pulmonari
ventil
function
bronchial
dilat
test
routin
clinic
chemic
analys
conduct
use
fast
blood
sampl
tianjin
haih
hospit
lcmsbase
serum
metabol
profil
serum
sampl
prepar
describ
briefli
protein
precipit
perform
serum
sampl
aliquot
drawn
sampl
four
volum
acetonitril
intern
standard
mixtur
carnitin
carnitin
carnitin
lpc
free
fatti
acid
ffa
ffa
chenodeoxychol
cholic
leucineenkephalin
ad
thorough
vortex
centrifug
g
min
two
aliquot
supernat
pipet
dri
centrivap
centrifug
vacuum
concentr
labconco
mo
dri
residu
store
analysi
lcmsbase
metabol
profil
perform
ultrahighperform
liquid
chromatograph
water
usa
coupl
tripletof
plu
mass
spectromet
appli
biosystem
foster
citi
ca
equip
electrospray
sourc
dri
serum
sampl
dissolv
acetonitril
acn
water
vv
follow
centrifug
supernat
load
posit
mode
beh
mm
mm
water
milford
column
use
gradient
initi
b
mobil
phase
formic
acid
acn
maintain
min
follow
linearli
increas
b
within
min
b
min
maintain
min
mobil
phase
rapidli
chang
formic
acid
within
min
total
run
time
inject
min
includ
postequilibr
min
tabl
differenti
phosphatidylinositol
serum
steroidtr
nonsar
patient
sever
pneumonia
versu
nonsar
patient
sever
pneumonia
without
steroid
treatment
scientif
report
gcmsbase
serum
metabol
profil
derivat
procedur
data
acquisit
perform
describ
previous
modif
briefli
temperatur
oxim
silyl
reaction
chang
oxim
reaction
time
reduc
h
serum
metabol
profil
perform
pseudotarget
mode
use
gcmsqp
plu
quadrupol
mass
analyz
coupl
autosampl
shimadzu
kyoto
japan
chromatograph
separ
perform
ms
capillari
column
j
w
scientif
folsom
ca
first
qualiti
control
qc
sampl
analyz
full
scan
mode
masstocharg
ratio
mz
scan
rang
dalton
obtain
target
ion
select
ion
monitor
sim
scan
paramet
full
scan
follow
flow
rate
carrier
ga
helium
constant
mlmin
oven
temperatur
began
maintain
min
follow
linear
increas
final
hold
min
temperatur
inlet
interfac
ion
sourc
detector
voltag
set
kv
solvent
delay
min
event
time
initi
integr
sim
scan
tabl
batch
analysi
sampl
conduct
pseudotarget
mode
ms
paramet
set
use
full
scan
mode
event
time
adjust
lcm
analysi
raw
data
first
import
peakview
softwar
autom
peak
detect
align
integr
check
deriv
peak
tabl
known
metabolit
miss
rel
standard
deviat
greater
autom
peak
pick
extract
integr
manual
unknown
ion
detect
blank
sampl
delet
intens
proport
blank
sampl
compar
averag
intens
level
experiment
sampl
rule
appli
remov
peak
miss
valu
surpass
group
mass
spectrometri
respons
normal
gcm
lcm
analys
raw
peak
area
ion
metabolit
normal
adjac
qc
local
linear
regress
qc
intens
select
lipidom
analysi
peak
pick
perform
use
lipidview
softwar
ab
sciex
owe
complex
lipid
compound
detect
extract
ion
chromatogram
avoid
black
box
associ
automat
pretreat
data
adjust
integr
paramet
perform
certain
case
peak
area
detect
lipid
compound
normal
spike
lipid
intern
standard
accord
differ
lipid
class
